Study of SP-3164 in Relapsed or Refractory Non-Hodgkin's Lymphoma
Status:
Not yet recruiting
Trial end date:
2027-08-15
Target enrollment:
Participant gender:
Summary
The purpose of this research is to help researchers find out if SP-3164 is safe and if it may
be of benefit in the treatment of patients with Non-Hodgkin's lymphoma that has progressed
after prior treatment, or that never responded to previous treatment.